Bibliography

Export 7 results:
Filters: Keyword is *Blood Component Transfusion/ae [Adverse Effects]  [Clear All Filters]
2015
Menis M, Forshee RA, Anderson SA, McKean S, Gondalia R, Warnock R, et al. Posttransfusion purpura occurrence and potential risk factors among the inpatient US elderly, as recorded in large Medicare databases during 2011 through 2012. Transfusion//Transfusion. 2015;55(2):284-95.
2014
Abe T, Shimada E, Takanashi M, Takamura T, Motoji K, Okazaki H, et al. Antibody against immunoglobulin E contained in blood components as causative factor for anaphylactic transfusion reactions. Transfusion//Transfusion. 2014;54(8):1953-60.
Shaz BH. Bye-bye TRALI: by understanding and innovation. Blood//Blood. 2014;123(22):3374-6.
Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet//Lancet. 2014;384(9956):1766-73.
2013
Coppola N, Loquercio G, Tonziello G, Azzaro R, Pisaturo M, Di Costanzo G, et al. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology// J Clin Virol. 2013;58(1):315-7.
Bianco C, Dodd RY. Infectivity of occult hepatitis B from two different points of view. Transfusion// Transfusion. 2013;53(7):1379-81.
Berseus O, Boman K, Nessen SC, Westerberg LA. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion. 2013;53 Suppl 1:114S-123S.